In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An announcement from Recursion ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...

We recently published 12 Best Healthcare Stocks to Buy Under $30. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the best healthcare stocks. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is a ...

RXRX stock looks like a deep-value growth bet at just $5 and change. Though the technology is exciting, I’m not rushing into shares just yet. Nvidia made early investors rich, but there is a new class ...

LeBron James became the only player in the NBA with a no-trade clause on Wednesday when the Phoenix Suns bought out Bradley Beal's contract. A day later, another player joined him. Veteran point guard ...

‘All Bets Are Off’: Inside Microsoft’s AGI Clause Fight With OpenAI Your email has been sent The clause that could turn collaboration into separation Nadella didn’t think AGI would come this soon, but ...

For a couple of decades, Ellen Jovin co-ran a communication company with her husband to help executives better express themselves. Then, in 2018, outside a subway station in New York, she set up a ...

One of the many ways that Donald Trump‘s first presidential term was unprecedented is that his brazen self-dealing triggered multiple federal lawsuits alleging violations of the Emoluments Clause, or ...